Advertisement
Pharma
Subscribe to Pharma

The Lead

Cell Type Responsible for Scarring, Skin-cancer Growth Identified

April 17, 2015 3:12 pm | by Stanford University | News | Comments

A single cell type in the skin of mice is a major contributor to scarring after wound healing or radiation damage, and facilitates the growth of melanoma. Blocking the cell’s activity in humans may be possible with currently approved drugs.

Angiogenesis Inhibitors Undermined by Immune Cells, Says Study

April 17, 2015 2:57 pm | by University of California San Francisco | News | Comments

Research suggests strategy to prevent relapse after therapies targeting tumor blood vessels.

Wearable Device Slows Deadly Brain Tumors

April 15, 2015 9:14 am | by University of Virginia | News | Comments

A wearable device that emits low-level electrical fields can slow the progression of...

A Patch for Peanut Allergies

April 9, 2015 11:13 am | by Bevin Fletcher, Associate Editor | Articles | Comments

French biopharmaceutical company DBV Technologies moves closer to bringing its peanut allergy...

View Sample

FREE Email Newsletter

Experimental Cancer Drug Restores Memory in Mouse Model of Alzheimer’s

April 1, 2015 11:07 am | by Bill Hathaway, Yale University | News | Comments

Memory and as well as connections between brain cells were restored in mice with a model of Alzheimer’s given an experimental cancer drug.

Stanford Professor Receives $1M Stem Cell Grant for 'Bubble Boy' Disease

March 27, 2015 3:20 pm | by Stanford Medicine | News | Comments

With this award, Stanford has received a total of around $297 million from CIRM.

HIV Can Lodge Quickly in Brain After Infection

March 27, 2015 3:15 pm | by Bill Hathaway, Yale University | News | Comments

HIV can establish itself in the brain as soon as four months after initial infection.

Advertisement

Researchers Help Create 'Gold Standard' Method for Measuring Alzheimer's Disease

March 27, 2015 10:42 am | by Mark Wheeler, UCLA | News | Comments

A team of researchers has validated the first standardized protocol for measuring one of the earliest signs of Alzheimer’s disease.

Tuberculosis Research Takes Off

March 25, 2015 10:53 am | by Max Planck Institute | News | Comments

Scientists call for a global strategy for the development of new tuberculosis vaccines.

Behind the Measles Outbreak

March 24, 2015 11:23 am | by Tom Ulrich, Harvard | News | Comments

Study finds vaccination rate far below what's needed to keep virus in check.

Non-FDA Approved Hormone Therapies on the Rise

March 24, 2015 11:06 am | by Cynthia Fox, Science Writer | Articles | Comments

Use of potentially risky, non-FDA approved hormone therapies may soon be as common as use of FDA-approved hormone therapies, according to a study by University of Virginia gynecology researcher JoAnn Pinkerton.

Google Teams With MIT, Harvard for Genetics Research Project

March 23, 2015 9:48 am | by Ryan Bushey, Associate Editor | News | Comments

The project will focus on finding cures for aging-related diseases like cataracts and atherosclerosis.

Advertisement

Liberians Overcome Fear to Volunteer For Ebola Vaccine Trial

March 23, 2015 9:47 am | by Jonathan Paye-Layleh, Associated Press | News | Comments

Liberians are overcoming their fears of Ebola to volunteer for a vaccine trial.

New Hope for Beating Deadly Hereditary Stomach and Breast Cancers

March 20, 2015 10:07 am | by University of Otago | News | Comments

Deadly familial stomach and lobular breast cancers could be successfully treated at their earliest stages, or even prevented, by existing drugs that have been newly identified by University of Otago cancer genetics researchers.

Apple's ResearchKit Must Outlast Novelty Value to Aid Medical Insight

March 17, 2015 10:03 am | by Niharika Midha, MSc, GlobalData Medical Device Analyst | Articles | Comments

Apple's ResearchKit needs to make an impact beyond the initial launch period.

Is HRT for Menopause Staging a Comeback?

March 16, 2015 2:08 pm | by Cynthia Fox, Science Writer | Articles | Comments

Many recent meta-studies find hormone replacement therapy lengthens life after all. This may be leading to a comeback for the once hugely popular menopause treatment.

Study: Tetanus Shot May Aid Treatment of Deadly Brain Cancer

March 12, 2015 10:09 am | by Malcolm Ritter, AP Science Writer | News | Comments

Can a tetanus shot help treat brain cancer? A small study hints that it might.

Advertisement

Genetic Test Maker 23andMe Launches Drug R&D Effort

March 12, 2015 9:15 am | by Associated Press | News | Comments

Google-backed genetic testing company 23andMe is launching its own drug development unit, betting that it can translate its database of customer DNA information into novel medicines.                                                                      

Skin Tumors Develop Specific Mutations to Resist Drug

March 11, 2015 10:26 am | by Krista Conger, Stanford School of Medicine | News | Comments

Basal cell carcinomas develop mutations in a protein on the Hedgehog pathway to evade a common drug therapy. Targeting another portion of the pathway may be an effective alternative treatment.                                                            

Specialty Drugs Drive Prescription Spending Jump

March 11, 2015 9:16 am | by Associated Press | News | Comments

Prescription drugs spending jumped 13 percent last year, the biggest annual increase since 2003, according to the nation's largest pharmacy benefits manager.                 

Stanford Showcases New App for Studying Heart Health

March 10, 2015 4:07 pm | by Ryan Bushey, Associate Editor | Videos | Comments

Apple teamed up with a handful of universities to create these medical research applications.                            

Childhood Leukemia Study Reveals Disease Subtypes, New Treatment Option

March 10, 2015 10:12 am | by Pete Farley, UCSF | News | Comments

One of every eight patients might benefit from highly successful lymphoma drugs.                              

Breakthrough Therapies Target Cancers in 2015

March 10, 2015 9:39 am | by Bevin Fletcher, Associate Editor | Articles | Comments

Getting a new drug to market is difficult, but the U.S. Food and Drug Administration (FDA) offers a number of ways to help the process along for promising drugs that have potential against serious diseases.  One of these options is designation as a breakthrough therapy. This year a number of these therapies are targeted at fighting cancer.

Apple Unveils New Medical Software Called ResearchKit

March 9, 2015 1:37 pm | by Ryan Bushey, Associate Editor | Articles | Comments

Apple showcased new health programs called Research Kit during a press conference today.                            

Scientists Find Direct Link Between Insulin Resistance in the Brain and Behavioral Disorders

March 3, 2015 10:14 am | by Joslin Diabetes Center | News | Comments

Study in mice identifies mechanism that lowers levels of dopamine and heightens behavior suggesting anxiety and depression.                       

Team Shows How Rare Antibody Targets Ebola and Marburg Viruses

March 2, 2015 10:37 am | by TSRI | News | Comments

Future treatments could bind to vulnerable site in viruses causing a variety of diseases.                            

New Molecule Could Slow Progression of Parkinson's

February 26, 2015 10:22 am | by University of Bath | News | Comments

Researchers have designed a molecule that, if developed into a drug, could slow the progression of Parkinson's Disease.                       

Researchers Redefine Role of Brain's 'Hunger Circuit'

February 25, 2015 9:54 am | by Pete Farley, UCSF | News | Comments

Unexpected findings have implications for anti-obesity therapies.                                

Telemedicine Set to Bloom in 2015

February 24, 2015 1:39 pm | by Steve Boccone, Greybox Communications | Articles | Comments

New technologies will help the field of telemedicine drastically grow this year.                              

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading